Investorideas.com - Cannabis Stock News: BevCanna (CSE: BEV) Signs LOI with Californian Cannabis Beverage Brand Calexo
www.investorideas.com - news that inspires big ideas
Thursday 26 March 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 389 (TSX: $TGOD.TO) (OTC: $TGODF), (TSXV: $NRTH.V) (TSX: $ALEF.TO) (OTC: $ALEAF)
Investor Ideas #Potcasts,
#Cannabis News and #Stocks on the Move; Episode 389 (TSX: $TGOD.TO) (OTC: $TGODF),
(TSXV: $NRTH.V) (TSX: $ALEF.TO) (OTC: $ALEAF)
Delta, Kelowna, BC, March 26, 2020
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s podcast edition of cannabis
news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read
this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/03261TGOD-NRTH-ALEF.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In today’s podcast we are looking at a few
company announcements.
Starting with, Cannalogue, who has
submitted an application to Health Canada to
conduct a real-world clinical trial with medical cannabis for COVID-19
(Coronavirus). If approved by Health Canada, Cannalogue will enroll
patients into the research study to determine if medical cannabis can reduce
the symptoms caused by COVID-19 or any mutant strains of coronavirus.
"Cannalogue is committed to doing our
part. The need is too great and we have to act now," says Dr. Mohan
Cooray, President and CEO of Cannalogue. Dr. Cooray, who is also a specialist
in Internal Medicine, Gastroenterology, and Hepatology goes on to say, "We
are not suggesting with the current knowledge of medical cannabis that it is a
prevention, treatment or cure for COVID-19 or coronaviruses. However, plant
cannabinoids have naturally occurring immunomodulatory properties that
absolutely require expedited investigation given the current global COVID-19
pandemic," he says.
Cannalogue is responding to the call by the
Honourable Prime Minister of Canada to enforce wartime measures and for all
Canadian businesses to stand united in the fight against COVID-19. The
specialists at Cannalogue believe the active medical ingredients from the
cannabis plant could potentially boost the immune system to reduce the severity
of symptoms from COVID-19.
"Cannabinoid receptors are naturally found
on immune cells in the body. If stimulated prior to an infection, it may
dampen the inflammatory response that follows, which is a key factor in the
severity of symptoms observed in patients," says Dr. Cooray.
"This appears to be a common mechanism of action for the current therapies
being investigated for COVID-19 research studies. If we can't flatten the curve, then we need
to focus on reducing the number of deaths," he says.
In support of the medical cannabis sector and
scientific research community, Cannalogue will be releasing an exclusive insider
health report that reveals key medical insights on emerging therapeutic areas
with respect to medical cannabis.
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF),
announced that, due to market conditions, it is
adapting operations and aggressively reducing costs.
The Company has postponed the start up of its
Valleyfield facility in order to centralize cultivation operations at
Ancaster. The Ontario facility is able to produce larger volumes than
initially anticipated, enabling the Company to delay cultivation operations in
Valleyfield saving costs and capital. The Company has temporarily laid off the
majority of its Valleyfield employees and intends to restart operations there
later in the year. Ancaster is not impacted and continues to grow and harvest
premium organic cannabis for the recreational and medical markets.
This change does not impact TGOD's timeline for
the launch of its remaining Cannabis 2.0 products, with Infusers already
launched and organic teas and vapes still on track to become available at the
end of next month.
TGOD expects to imminently receive its licence
amendment from Health Canada for the processing facility at Ancaster. Once it
is received, the Company will be able to automate many of its processes
reducing costs and further accelerating production.
As it continues to work towards becoming EBITDA
and operating cash flow positive later this year, beyond the cost savings
generated with the Valleyfield operation postponement, TGOD has undertaken
another series of measures to aggressively reduce costs. This includes:
- Temporary salary reductions
of 20% for salaried employees and 30% for certain executives
- A freeze on all non-essential
recruitment and consultancy work
- Working with suppliers to
identify further cost savings and efficiencies
"Multiple factors, most particularly the
COVID-19 pandemic, are contributing to an environment in which we must be
extremely prudent with how we manage our cost structure. These are
unprecedented times, and the situation continues to evolve. With the support and unity I have seen from
our employees, partners and stakeholders, I am very confident that TGOD can
tackle this challenge and come out much stronger," commented Brian
Athaide, CEO of TGOD. "We have seen very strong consumer and medical
patient feedback from our recent TGOD Infusers launch and are looking forward
to having them available in more stores quickly. These along with our upcoming additional 2.0
products are very unique and deliver superior consumer experiences which will
help further differentiate and build our TGOD organic brand positioning,"
continued Athaide.
48North Cannabis Corp. (TSXV:NRTH), announced that it has shipped the first order of its vape
product Avitas to the Ontario Cannabis Store for retail sale. The Avitas
vape marks the Company's first vape product available for sale.
Avitas,
available in over 500 stores in Washington, Oregon and Colorado is one of the
best-selling single strain vaporizer cartridges in the United States and
represents 48North's first product introduction as part of its vaporizer
strategy. Avitas develops 100% additive free, single strain,
ultra-refined and purified, vaporizer cartridges. Single strain vaporizer
cartridges represent the fastest-growing, next-generation cannabis product
category in the United States.
To
start, 48North will be launching a Super Citrus Haze vaporizer
cartridge, using flower that has been hand selected for flavor, aroma and
cannabinoid profile. This unique sativa forward strain is earthy and citrusy to
the tongue with terpenes that evoke herbs like black pepper and cloves. The
Company uses a gentle extraction method to preserve the flower's cannabinoid
and terpene profiles, resulting in single strain, full spectrum oils – clean
and simple.
Successfully
launching the company's first vape product to market is indicative of 48North's
renewed commitment to improving operations, investing in product design,
and supporting high-quality experiences for Canadian consumers.
"Since
the beginning, 48North has been committed to selling next-generation cannabis
products to Canadian consumers. In response, the company has built landmark
partnerships with brands like Apothecanna and Avitas to bring some of the
highest-quality products to consumers. Bringing market-tested brands from the
United States to Canada has been part of the 48North strategy from the
beginning. In doing so, we capitalize on a head-start with brand building and
fostering consumer loyality. We very excited to share this product with
Canadians across the country," said Kirsten Gauthier, CMO of 48North.
Aleafia Health Inc. (TSX:
ALEF) (OTC:
ALEAF) announced launching its last-mile medical cannabis home
delivery service. It will provide patients next-day, direct-to-home delivery on
medical cannabis orders made in Ontario’s Greater Golden Horseshoe Region, home
to over 9 million people.
By delivering directly to patients’ homes, the
service provides safe, contactless delivery, eliminating the need for customers
to pick-up products at post offices and post boxes. It also mitigates the risk
to the Company of disruption of postal and third-party parcel delivery services
during the COVID-19 pandemic.
The initial GGHR launch is anticipated to occur
during the next two weeks, with a planned subsequent expansion to new Canadian
markets, and the introduction of same-day, scheduled delivery.
“By controlling the last mile of our supply
chain, we are providing a unique service to patients who want fast, secure and
convenient access to their medicine,” said Aleafia Health CEO Geoffrey Benic.
“Adapting to this challenging environment is critical. In addition to launching
home delivery, earlier this month we transitioned to conducting 100 per cent of
patient consultations remotely through telemedicine, with the goal of not
missing a single patient appointment.
“Having said that, introducing home delivery has
been long in the works and will be a permanent feature that we offer moving
forwards.”
Aleafia Health’s home delivery benefits from the
supply chain logistics experience of Benic and COO Greg Rossi, who were among
the founding partners of the award winning online grocery fulfillment and
delivery service, GroceryGateway.com. The pair have also worked as executive
consultants on supply chain logistics projects for some of the world’s largest
companies including Walmart Inc., Nestlé S.A., Kraft Heinz Company, Campbell
Soup Company and Mondelez International. Benic and Rossi were also the
architects of Trust Delivery, the first and only same-day Canadian medical
cannabis delivery service.
Now lastly we look at two stories linking the
alcohol industry with the cannabis sector, and how the alcohol industry is now
adopting methods from the cannabis sector as their roles in society are
reversed.
One company, Boozer Inc. announced the launch of a Canada-wide click-and-collect
initiative in response to the continuing COVID-19 public health challenge.
Complementing our existing same-day delivery platform, the click-and-collect
feature will allow Canadian alcohol retailers, including independent retailers,
craft breweries and distilleries, to stay open for business using the Boozer
e-commerce platform for 'take-out' and 'delivery'.
The click-and-collect service will allow
age-permitted users to order their favourite alcoholic beverages and products
for on-demand pickup from a licensed retail location near them, all through the
existing Boozer platform. Employing an e-commerce solution allows both the
customers and retail staff to maintain social distancing to the extent they
feel comfortable, or as required by local authorities. "Retailers now more
than ever need to provide a safe environment for consumers to purchase
products. Today retailers are effectively needing to turn in-store shoppable
retail spaces into click-and-collect and delivery fulfillment centers.
We are looking to support this activity by moving
forward with this initiative that will keep local retail stores open and to
provide much needed assistance to the retail sector," commented Michael
Kniazeff, CEO and Co-Founder of Boozer.
"Click-and-collect is well adopted by
consumers in the grocery and restaurant industries, and we're excited to bring
this convenient experience to the retail alcohol space," commented Ian
Delves, President and Co-Founder of Boozer. "On the delivery front, like
others Boozer has been seeing massive spikes in demand over the past week. We
see the launch of click-and-collect as a way to help alleviate some of the
strain the entire delivery community has been dealing with, as we navigate this
unprecedented lift in orders," he added.
The National Association of Cannabis Businesses (NACB) today
announced the appointment of Mark Gorman as its new
Executive Vice President and Chief Operating Officer. The NACB is the only
cannabis industry trade group dedicated to promoting national standards for
responsible advertising and marketing of cannabis products, as well as other
best practice guidelines for businesses in the burgeoning sector.
Gorman joins NACB from the Distilled Spirits
Council of the United States (DISCUS), where he served 20 years as the Senior
Vice President for Government Relations overseeing the distilled spirits
industry’s highly successful legislative, public policy and advocacy activities
at both the federal and state levels.
“We are delighted to have Mark join our team as
the leader of our governmental policy and outreach efforts,” said Gina
Kranwinkel, NACB’s President and CEO. “Mark’s depth of experience with the
challenges faced by highly regulated industries make him an ideal fit with our
organization.”
Under Gorman’s direction, the NACB will work to
broaden support among other cannabis groups, consumer protection agencies and
government policy makers for its responsibility standards and best practice
guidance.
“The distilled spirits industry weaves
responsibility into every facet of its business from advertising and marketing
practices to public policy and education initiatives. This commitment to
responsibility has earned the industry respect on Capitol Hill and credibility
in state capitols across the country. I
look forward to applying this experience to help the NACB develop a successful
legislative and regulatory path forward,” Gorman said.
Prior to joining DISCUS, Mark spent seven years
leading government affairs at the National Restaurant Association and several
years as deputy director at the Washington office of General Mills, Inc. He is
also a Capitol Hill veteran having worked six years as a tax legislative
assistant for Sen. John H. Chafee (R-RI).
The NACB, which was established in 2017,
represents over 400 member-businesses and thousands of cannabis professionals
around the country. They are the industry’s first and only self-regulatory organization,
whose mission is to support the compliance, transparency and growth of legal
cannabis businesses in the U.S.
Investor ideas reminds all listeners to read our
disclaimers and disclosures on the
Investorideas.com website and this podcast is not
an endorsement to buy products or services or securities. Investors are
reminded all investment involves risk and possible loss of investment
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and
Tunein.
Potcasts is
now a certified word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news, research and original financial content.
Learn about investing in stocks and sector trends with our news alerts,
articles, podcasts and videos, looking at cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s
original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move
podcast and column, Cleantech and
Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact management and IR of each company directly
regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Contact Investorideas.com
800 665 0411
Tuesday 24 March 2020
Investorideas.com - Cannabis Stock News: Village Farms International (TSX: $VFF.TO) (NASDAQ: $VFF) Completes $11.5 Million Public Offering of Common Shares, Including Exercise of Over-Allotment Option
Investorideas.com - Cannabis Stock News: Village Farms International (TSX: $VFF.TO) (NASDAQ: $VFF) Completes $11.5 Million Public Offering of Common Shares, Including Exercise of Over-Allotment Option
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 388 - Cannabis Deemed Essential (CSE: $SHRM.C)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 388 - Cannabis
Deemed Essential (CSE: $SHRM.C)
Delta, Kelowna, BC, March 24, 2020 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we are looking at how the COVID-19 Pandemic has pushed cannabis
fully away from fringe to “essential” and how psilocybin could be next.
A
recent
Forbes article discussed how, “In state after state, governors and public health officials are
deeming cannabis businesses “essential” operations that can stay open amid
coronavirus-related forced closures and stay-at-home mandates. People might not
be able to go bowling or see a movie in theaters, but they can still stock up
on marijuana.”
The article continues to discuss which states have declared
cannabis essential, such as California, and how even some states where cannabis
business was still being scrutinized heavily have even allowed the continuation
of medical and recreational cannabis operations.
In Canada, in recent news,
“Ontario
Premier Doug Ford announced Monday that all non-essential businesses in the
province will be required to shut down effective Tuesday at 11:59 p.m. for a
period of at least 14 days. A list of businesses that will remain open will be
released Tuesday, the government said in a release.”
The
article continued saying that, “Licensed cannabis stores will remain open in
Ontario during a provincial emergency shutdown of non-essential businesses
designed to limit the spread of COVID-19, according to two sources directly
familiar with the matter.”
Now
as cannabis pushes from recreational pass-time or fringe medication to
“essential” medication in North America, this is driving the push for another
fringe drug with massive potential, psilocybin.
There
has been a meme floating around the internet as of late during the COVID-19
Pandemic (image below), and while this may seem silly to some, many are taking
this opportunity to push local governments into reconsidering magic mushrooms.
In other recent news
from California, “a campaign to legalize psilocybin mushrooms in California is
asking the state to allow online signature gathering for their ballot petition,
arguing that the coronavirus outbreak necessitates an alternative means to put
the psychedelic reform measure before voters in November.”
Decriminalize
California, the group behind the proposed initiative, partnered with two other
campaigns in the state to write a letter to the governor, secretary of state
and attorney general, requesting the emergency policy change. It’s the latest
in a series of similar requests from drug policy reform campaigns across the
U.S., with activists scrambling to qualify their measures for state ballots
amid the pandemic.
In
news from Hawaii, “Two
members of the Hawaii Legislature introduced a set of resolutions aimed at
studying the medicinal applications of psilocybin in order to develop a plan
that ensures the availability of the compound for adult patients in the state.”
This leads to
companies like Champignon Brands Inc. (CSE:
SHRM), a health and wellness company specializing in the
formulation of a suite of medicinal mushrooms and mushroom-infused products,
who recently
introduced new proprietary intellectual property into
its vertically integrated alternative medicine product range. The Company
announced its entry into a definitive agreement, signed March 18, 2020, to
acquire Novo Formulations Ltd.
Novoformulations’
novel delivery system platforms, as well as complementary R&D advancements,
will accelerate the architecture of Champignon’s patent portfolio as the
Company persists in being a first mover in the existing consumer package goods
and emerging psychedelic medicine arenas.
Novoformulations is
a specialty biotechnology company focused on developing novel and innovative
delivery systems for the pharmaceutical and nutraceutical industries. The
Novoformulations team consists of a roster of PhDs and technician level scientists,
each with decades of experience building novel defensible medical IP, as well
as subsequently developing and commercially marketing proprietary delivery
platforms.
Novoformulations is
presently working with ketamine, anaesthetics and adaptogenics, as well as a
host of pharmaceuticals and natural molecules at a purpose-built GMP and
pharmaceutical (DIN) licensed facility located in Quebec, Canada, and an
accredited pharmacy in Ontario. There, the Company is actively formulating,
developing and commercializing bioavailable delivery platforms, including:
●
Transdermal (topical);
●
Intranasal;
●
Sublingual; and,
●
Novel oral and suppository.
Also based in
Quebec, Novoformulations’ manufacturing partner will process its novel delivery
platforms and formulations into marketable end products at its
40,000-square-foot GMP-certified, Health Canada and Federal Drug Administration
(FDA)-approved manufacturing facility.
Champignon plans to
leverage Novoformulations’ existing product development infrastructure and
licensed affiliates to pursue psilocybin and MDMA based formulations, with the
objective of developing and commercializing rapid onset treatments capable of
improving health outcomes, including Depression, PTSD and substance and alcohol
use disorders (DPS). The current marketplace for pharmacologic DPS treatments
in North America exceeds $10 billion annually.1
“The recent
acquisitions of Novoformulations and Artisan Growers are absolutely accretive
to each other and to our stated business objectives of enhancing the health and
wellbeing of millions of consumers via our suite of medicinal mushroom
extracts, mushroom-infused products and now novel delivery systems,” Champignon
Chief Executive Officer Gareth Birdsall commented.
“The existing infrastructure inherited from
these recent acquisitions positions us as a leading participant throughout the
entire alternative medicine lifecycle, from R&D to formulation,
manufacturing and end distribution. The end result will be a turnkey solution
that incorporates both standardized ingredient mixtures and pharmaceutical
grade products that can now be marketed via a variety of proprietary delivery
systems,” continued Gareth Birdsall. “The addition of Novoformulations allows
Champignon to deliver medications in a safer, more effective and more
expeditious manner than our peers, from bench top in the laboratory, to
preclinical and clinical trials. We are intent on the commercialization of
products throughout North America, as rapidly as is safely and effectively
practicable."
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration
Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Contact Investorideas.com
800
665 0411
Subscribe to:
Posts (Atom)
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...